Chinese pharmaceutical company Chengdu Kanghong Pharmaceutical Group plans to increase its stake in a pharmaceutical unit in Chengdu for a consideration of $10.8 million.

The company already holds a 93% stake in the target company, while the proposed acquisition will increase the same to 100%.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

“The company already holds a 93% stake in the target company, while the proposed acquisition will increase the same to 100%.”

In another proposal by a Chinese company, Cachet Pharmaceutical, a majority stake of 51% is intended to be acquired in a pharmaceutical company based in Xi’an, China.

The deal value is proposed to be ¥18 million ($2.67 million).

US-based Antegrin Therapeutics and Cascadia Therapeutics have announced the completion of their merger.

The merged entity, named Indalo Therapeutics, aims to develop treatments for fibrotic diseases.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now